Peek behind the paper: mesenchymal stromal cells for the treatment of COVID-19

Written by RegMedNet

In this peek behind the paper, Massimiliano Gnecchi provides insights into his recent article published in Stem Cells Translational Medicine on how mesenchymal stromal cells (MSCs) are not infected with SARS-CoV-2 and could potentially be safe if used as a treatment for COVID-19.  Please can you introduce yourself and tell us more about your role?  My name is Massimiliano Gnecchi, an intensivist cardiologist with a passion for research. In fact, for many years, in addition to the care of my patients, I have been involved in basic and clinical research. I am currently Associate Professor at the University of Pavia...

To view this content, please register now for access

It's completely free